Maple Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $728K | Buy |
3,922
+493
| +14% | +$91.5K | 0.05% | 65 |
|
2025
Q1 | $718K | Buy |
3,429
+1,092
| +47% | +$229K | 0.06% | 65 |
|
2024
Q4 | $415K | Buy |
2,337
+497
| +27% | +$88.3K | 0.03% | 83 |
|
2024
Q3 | $363K | Sell |
1,840
-225
| -11% | -$44.4K | 0.03% | 87 |
|
2024
Q2 | $354K | Buy |
2,065
+5
| +0.2% | +$858 | 0.03% | 92 |
|
2024
Q1 | $375K | Sell |
2,060
-107
| -5% | -$19.5K | 0.03% | 82 |
|
2023
Q4 | $336K | Buy |
2,167
+805
| +59% | +$125K | 0.03% | 79 |
|
2023
Q3 | $203K | Buy |
+1,362
| New | +$203K | 0.02% | 94 |
|
2023
Q1 | – | Sell |
-1,284
| Closed | -$208K | – | 98 |
|
2022
Q4 | $208K | Sell |
1,284
-77
| -6% | -$12.4K | 0.03% | 92 |
|
2022
Q3 | $207K | Buy |
+1,361
| New | +$207K | 0.03% | 89 |
|
2022
Q2 | – | Sell |
-1,361
| Closed | -$221K | – | 92 |
|
2022
Q1 | $221K | Buy |
+1,361
| New | +$221K | 0.03% | 95 |
|
2015
Q4 | – | Sell |
-84,817
| Closed | -$4.62M | – | 127 |
|
2015
Q3 | $4.62M | Sell |
84,817
-2,960
| -3% | -$161K | 1.71% | 23 |
|
2015
Q2 | $5.9M | Sell |
87,777
-1,449
| -2% | -$97.4K | 2.02% | 18 |
|
2015
Q1 | $5.22M | Buy |
89,226
+43,828
| +97% | +$2.57M | 1.82% | 22 |
|
2014
Q4 | $2.97M | Buy |
45,398
+1,048
| +2% | +$68.6K | 1.08% | 38 |
|
2014
Q3 | $2.56M | Sell |
44,350
-1,125
| -2% | -$65K | 0.97% | 40 |
|
2014
Q2 | $2.57M | Sell |
45,475
-710
| -2% | -$40.1K | 0.93% | 44 |
|
2014
Q1 | $2.37M | Sell |
46,185
-1,303
| -3% | -$67K | 0.92% | 44 |
|
2013
Q4 | $2.51M | Sell |
47,488
-500
| -1% | -$26.4K | 1% | 40 |
|
2013
Q3 | $2.15M | Sell |
47,988
-2,930
| -6% | -$131K | 0.95% | 41 |
|
2013
Q2 | $2.11M | Buy |
+50,918
| New | +$2.11M | 0.94% | 43 |
|